SCHEMBL6384256

SCHEMBL6384256

CCCCN(C)C(=O)c1ccc(C(=O)Nc2ccccc2NC(=O)OC(C)(C)C)s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.41
CSNK2A2 P19784 2/20 0.39
CSNK2B P67870 2/20 0.39
CSNK2A1 P68400 2/20 0.39
KDR P35968 1/20 0.39
RXFP1 Q9HBX9 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
LMNA P02545 3/20 0.36
MEN1 O00255 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
PKM P14618 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36
CTSK P43235 2/20 0.36
METAP1 P53582 1/20 0.36
NAMPT P43490 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6384160 0.81 CA12 (0.45) CSNK2A2CSNK2BCSNK2A1KDRSMN1; SMN2
SCHEMBL6383174 0.78 CA12 (0.44) CNR2CSNK2A2CSNK2BCSNK2A1KDR
SCHEMBL3786249 0.78 SMN1; SMN2 (0.45) RXFP1SMN1; SMN2LMNAMEN1HTT
SCHEMBL3791523 0.77 SMN1; SMN2 (0.47) RXFP1SMN1; SMN2LMNAMEN1KMT2A
SCHEMBL4470283 0.77 NPC1 (0.42) RXFP1SMN1; SMN2LMNAMEN1HTT
SCHEMBL5224142 0.75 POLB (0.60) RXFP1SMN1; SMN2LMNAMEN1HTT
SCHEMBL6076256 0.74 SMN1; SMN2 (0.41) RXFP1SMN1; SMN2LMNAMEN1HTT
SCHEMBL2733475 0.73 SMN1; SMN2 (0.42) RXFP1SMN1; SMN2LMNAMEN1HTT
SCHEMBL2880191 0.71 LMNA (0.54) CNR2RXFP1SMN1; SMN2LMNAMEN1
SCHEMBL6076142 0.70 AKT1 (0.37) RXFP1SMN1; SMN2LMNAMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1592667-A2 NEW MONO-ACYLATED O-PHENYLENDIAMINES DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-11-09 EP disclosed
WO-2004069803-A2 MONO-ACYLATED O-PHENYLENDIAMINES DERIVATIVES AND THEIR USE AGAINST CANCER F. HOFFMANN-LA ROCHE AG (CH) 2004-08-19 WO disclosed